Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome

Nicole Maharaj; Steven Swarath; Rajeev Seecheran; Valmiki Seecheran; Avidesh Panday; Naveen Seecheran

doi:10.7759/cureus.34236

Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome

Cureus. 2023 Jan 26;15(1):e34236. doi: 10.7759/cureus.34236. eCollection 2023 Jan.

Authors

Nicole Maharaj¹, Steven Swarath¹, Rajeev Seecheran², Valmiki Seecheran¹, Avidesh Panday¹, Naveen Seecheran³

Affiliations

¹ Medicine, North Central Regional Health Authority, Port of Spain, TTO.
² Internal Medicine, University of Kansas School of Medicine, Wichita, USA.
³ Cardiology, The University of the West Indies, St. Augustine, TTO.

Abstract

We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.

Keywords: autonomic dysfunction; coronavirus disease 2019; covid-19; dysautonomia; mrna vaccine; pfizer-biontech; pfizer-biontech covid-19 vaccine; postural orthostatic tachycardia syndrome; postural orthostatic tachycardia syndrome (pots).

Publication types

Case Reports